IP Verse

Glenmark Pharmaceuticals Europe patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest oppositions filed by Glenmark Pharmaceuticals Europe

Explore patent oppositions filed by Glenmark Pharmaceuticals Europe against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3578175
Rapid Dissolution Formulation Of A Calcium Receptor-Active CompoundAMGENAug 30, 2023
EP2653873
Compositions And Uses For Treating Multiple SclerosisBIOGEN IDEC MAApr 19, 2023
EP2959894
S1P Receptor Modulators For Treating Multiple SclerosisNOVARTISOct 12, 2022
EP2817000
Oral Pharmaceutical Compositions Of Dabigatran EtexilateESTEVE PHARMACEUTICALSApr 14, 2022
EP2478907
Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGYJan 14, 2022
EP2493466
Novel Antitumoral Use Of CabazitaxelAVENTIS PHARMAMar 10, 2021
EP3395338
Rapid Dissolution Formulation Of Cinacalcet HclAMGENJan 27, 2020
EP3260117
Rapid Dissolution Formulation Of A Calcium Receptor-Active CompoundAMGENJan 16, 2020
EP3395339
Rapid Dissolution Formulation Of A Cinacalcet HclAMGENJan 16, 2020
EP3395340
Rapid Dissolution Formulation Of Cinacalcet HclAMGENJan 16, 2020

Top competitors of Glenmark Pharmaceuticals Europe

List of top competitors of Glenmark Pharmaceuticals Europe based on patent oppositions.